Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
juvederm volite xc
- Development stage
- Unknown
- Lead developer
- Allergan
- Modality
- Small Molecules
- Administration
- Intradermal
01
Overview
Juvéderm Volite XC is an **injectable gel** containing cross-linked **hyaluronic acid** and lidocaine, developed for *improving skin quality factors such as hydration, elasticity, and fine lines* through **intradermal injection**. Its unique Vycross technology blends high- and low-molecular-weight hyaluronic acids, prolonging its retention in the skin and allowing for a more natural, long-lasting effect—up to 9 months with minimal maintenance. The lidocaine is included to reduce discomfort during injection. Volite XC is *not a volumizing filler* but rather a **skin booster** for superficial cutaneous improvement and is approved as a medical device in Japan for aesthetic medicine.
- Brand names
- Juvederm Volite XCJuvederm Vista Volite XC
- Other names
- volite xc
02
Targets
Gag (HIV-1 Gag polyprotein)AQP1 (Aquaporin-1)
Beyond the preview
Go deeper on juvederm volite xc.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on juvederm volite xc.